Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using ...

Monoclonal gammopathy subtypes, especially IgM-MG, define distinct clinical subsets in CLL, impacting therapeutic outcomes significantly. IgM-MG is linked to poorer prognostic indicators, including ...

This paradigm-shifting finding redefines our understanding of how antibodies defend the body and could pave the way for next-generation antibody-based therapies. Many bacteria experience mechanical ...

WM management has shifted from toxic chemotherapies to targeted therapies, such as BTK inhibitors, enhancing patient outcomes and reducing complications. Peripheral neuropathy, a common WM symptom, ...

Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the ...

Dr. Shirley D'Sa discusses the importance of catching peripheral neuropathy in patients with Waldenström macroglobulinemia early on and how to treat it. Waldenström macroglobulinemia (WM) is a type of ...

The following is a summary of “Kinetics of tick-borne encephalitis virus IgM antibody responses in serum and cerebrospinal fluid,” published in the March 2025 issue of Infectious Diseases by Morgardt ...